Monday, December 23, 2024
HomeTagsBlood Advances

Blood Advances

Rigel Announces Publication of REZLIDHIA™ Phase 2 Clinical Results in Blood Advances

Rigel Pharmaceuticals, Inc.  announced a peer-reviewed publication of data in Blood Advances, which summarizes clinical results from the Phase 2 registrational study of REZLIDHIA™, a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics